BLACKSBURG, Va., Sept. 10 -- Virginia Polytechnic Institute and State University issued the following news release:
How do we know when cancer treatments work and when they don't? And how can we improve diagnostic technology and interpret the results so that every patient gets the right treatment at the right time?
For Christopher Hourigan, those questions get to the heart of precision medicine.
Hourigan, an oncologist and physician-scientist who directs the Fralin Biomedical Research Institute's Cancer Research Center in Washington, D.C., will open the 2026-27 Maury Strauss Distinguished Public Lecture season with "Why Measure?" at 5:30 p.m. Sept. 17 in Roanoke.
His answer to that question has been shaped by treating patients with canc...